Symbol="CAPR"
AssetType="Common Stock"
Name="Capricor Therapeutics Inc"
Description="Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California."
CIK="1133869"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="8840 WILSHIRE BLVD, 2ND FLOOR, BEVERLY HILLS, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="144797000"
EBITDA="-29379816"
PERatio="None"
PEGRatio="0"
BookValue="0.246"
DividendPerShare="0"
DividendYield="0"
EPS="-1.16"
RevenuePerShareTTM="0.223"
ProfitMargin="0"
OperatingMarginTTM="-5.43"
ReturnOnAssetsTTM="-0.316"
ReturnOnEquityTTM="-1.878"
RevenueTTM="5538200"
GrossProfitTTM="1746400"
DilutedEPSTTM="-1.16"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="61.69"
PriceToBookRatio="6.5"
EVToRevenue="35.42"
EVToEBITDA="-2.043"
Beta="3.963"
num_52WeekHigh="6.58"
num_52WeekLow="3.3"
num_50DayMovingAverage="4.621"
num_200DayMovingAverage="4.388"
SharesOutstanding="25269900"
DividendDate="2019-06-05"
ExDividendDate="None"
symbol="CAPR"
open="5.72"
high="5.96"
low="5.55"
price="5.90"
volume="245088.00"
latest_trading_day="2023-08-09"
previous_close="5.73"
change="0.17"
change_percent="2.9668%"
aroon_positive_momentum_days="73"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="73"
Volume_recent_avg="69649"
Change_recent_avg="0.01"
Delta_recent_avg="0.21"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="0.08"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="73"
Aroon_momentum_negative="27"
image_negative_thumbnail_id_1="1153"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0186.jpeg"
image_negative_thumbnail_id_2="1101"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0134.jpeg"
image_neutral_thumbnail_id_1="539"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0060.jpeg"
image_neutral_thumbnail_id_2="567"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_positive_thumbnail_id_1="969"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0131.jpeg"
image_positive_thumbnail_id_2="638"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0070.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
